Acarix AB (publ)

OTCPK:ACIX.F Stock Report

Market Cap: US$29.1m

Acarix Valuation

Is ACIX.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ACIX.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ACIX.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ACIX.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ACIX.F?

Key metric: As ACIX.F barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for ACIX.F. This is calculated by dividing ACIX.F's market cap by their current book value.
What is ACIX.F's PB Ratio?
PB Ratio5x
BookSEK 64.06m
Market CapSEK 320.75m

Price to Book Ratio vs Peers

How does ACIX.F's PB Ratio compare to its peers?

The above table shows the PB ratio for ACIX.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average2x
POCI Precision Optics Corporation
3.2xn/aUS$32.4m
STIM Neuronetics
3.1x47.5%US$26.9m
ADGM Adagio Medical Holdings
0.5xn/aUS$35.9m
OM Outset Medical
1x34.2%US$44.0m
ACIX.F Acarix
5x110.4%US$320.7m

Price-To-Book vs Peers: ACIX.F is expensive based on its Price-To-Book Ratio (5x) compared to the peer average (2x).

Price to Book Ratio vs Industry

How does ACIX.F's PB Ratio compare vs other companies in the US Medical Equipment Industry?

28 CompaniesPrice / BookEstimated GrowthMarket Cap
ADGM Adagio Medical Holdings
0.5xn/aUS$35.90m
CODX Co-Diagnostics
0.5x-8.3%US$32.25m
MHUA Meihua International Medical Technologies
0.1xn/aUS$18.77m
RVP Retractable Technologies
0.2xn/aUS$18.72m
ACIX.F 5.0xIndustry Avg. 2.6xNo. of Companies28PB0246810+
28 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: ACIX.F is expensive based on its Price-To-Book Ratio (5x) compared to the US Medical Equipment industry average (2.6x).

Price to Book Ratio vs Fair Ratio

What is ACIX.F's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ACIX.F PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio5x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate ACIX.F's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Patterson Companies

US$1.8b

Engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada.

PDCO

US$21.62

7D

3.4%

1Y

-32.2%

Centene

US$30.5b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.

CNC

US$61.43

7D

4.4%

1Y

-17.1%

electroCore

US$72.3m

A commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally.

ECOR

US$11.35

7D

17.6%

1Y

102.0%